(Q34172008)

English

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. (English)

1 reference

Europe PubMed Central

31 July 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

16

object named as

Sunil S Badve

1 reference

Europe PubMed Central

31 July 2017

object named as

Sylvia Adams

1

0 references

object named as

Sandra Demaria

3

0 references

Antonio C. Wolff

object named as

Antonio C Wolff

11

0 references

5

object named as

Edith A Perez

1 reference

Europe PubMed Central

31 July 2017

14

object named as

George W Sledge

1 reference

Europe PubMed Central

31 July 2017

15

object named as

Joseph A Sparano

1 reference

Europe PubMed Central

31 July 2017

author name string

Robert J Gray

2

1 reference

Europe PubMed Central

31 July 2017

Lori Goldstein

4

1 reference

Europe PubMed Central

31 July 2017

Lawrence N Shulman

6

1 reference

Europe PubMed Central

31 July 2017

Silvana Martino

7

1 reference

Europe PubMed Central

31 July 2017

Molin Wang

8

1 reference

Europe PubMed Central

31 July 2017

Vicky E Jones

9

1 reference

Europe PubMed Central

31 July 2017

Thomas J Saphner

10

1 reference

Europe PubMed Central

31 July 2017

William C Wood

12

1 reference

Europe PubMed Central

31 July 2017

Nancy E Davidson

13

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

1 September 2014

1 reference

Europe PubMed Central

31 July 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

31 July 2017

32

1 reference

Europe PubMed Central

31 July 2017

2959-2966

1 reference

Europe PubMed Central

31 July 2017

27

1 reference

Europe PubMed Central

31 July 2017

The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Radiation as an immunological adjuvant: current evidence on dose and fractionation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Use of archived specimens in evaluation of prognostic and predictive biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Weekly paclitaxel in the adjuvant treatment of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Nodal response in medullary carcinoma of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

5 July 2018

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

28 October 2018

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

28 October 2018

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

28 October 2018

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

28 October 2018

Robust variance estimation for the case-cohort design.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162494

28 October 2018

Cancer-testis antigen expression in triple-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25071121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Immunological aspects of anticancer chemotherapy]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25071121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte infiltrates as a prognostic variable in female breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25071121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting recommendations for tumor marker prognostic studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25071121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2013.55.0491

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34172008&oldid=1787861272"